Xiao Yu

3PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jun 19, 2026
CTSC-RAB38 Potentiates Responsiveness to PD-1 Blockade in Esophageal Squamous Cell Carcinoma.

|Feb 24, 2026
Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer.

Yabing Nan, Kunyu Wang, Menghan Hu

|Dec 13, 2023
RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression.

Xiao Yu, Pengfei Zhao, Qingyu Luo

Pageof 1

Frequent Collaborators

3 joint publications

Zhihua Liu

2 joint publications

Qingyu Luo

2 joint publications

Xiaowei Wu

2 joint publications

Zhumei Cui

1 joint publications

Yabing Nan

1 joint publications

Li Chen

1 joint publications

Wenyan Gao

1 joint publications

Wenqing Wei

1 joint publications

Shi Liu

1 joint publications

Hongyan Chen

Frequent Collaborators

3 joint publications

Zhihua Liu

2 joint publications

Qingyu Luo

2 joint publications

Xiaowei Wu

2 joint publications

Zhumei Cui

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us